Teva Pharmaceutical Industries Limited (TEVA) Investor Relations Documents

Teva Pharmaceutical Industries Limited (TEVA) investor relations documents from the company's IR site: 25 presentations, 9 press releases; latest deck 2026-07-29. Read in-app with summaries. First-party data.

Second Quarter 2026: Teva's July 29, 2026 presentation outlines risks and forward-looking statements, emphasizing competition, debt, and regulatory challenges. It also details Q2'26 financial results

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-07-29Earnings deckSecond Quarter 2026
2026-07-28Press releaseSecond Quarter 2026
2026-07-09Press releaseTeva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) fo
2026-07-07Press releaseTeva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in Vitiligo, Following
2026-06-18Press releaseTeva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome
2026-06-10Press releaseTeva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Gro
2026-06-08Press releaseTeva’s Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Highlight
2026-06-05Press releaseTeva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablet
2026-04-28Press releaseFirst Quarter 2026
2026-04-29Earnings deckFirst Quarter 2026
2026-04-29Quarterly reportFirst Quarter 2026
2026-04-08Earnings deckFourth Quarter 2025
2026-01-27Press releaseFourth Quarter 2025
2026-01-27Quarterly reportFourth Quarter 2025
2026-01-27Earnings deckQ4 2025 Fact Sheet (opens in new window)
2025-11-04Earnings deckThird Quarter 2025
2025-11-04Quarterly reportThird Quarter 2025
2025-11-03Earnings deckQ3 2025 Fact Sheet (opens in new window)
2025-09-25Quarterly reportThird Quarter 2025
2025-07-30Earnings deckSecond Quarter 2025
2025-07-30Quarterly reportSecond Quarter 2025
2025-07-29PresentationQ2 2025 Fact Sheet (opens in new window)
2025-06-26Quarterly reportSecond Quarter 2025
2025-05-07Earnings deckFirst Quarter 2025
2025-05-06PresentationQ1 2025 Fact Sheet (opens in new window)
2025-02-05PresentationQ4 024 Fact Sheet (opens in new window)
2025-01-29Earnings deckFourth Quarter 2024
2024-11-06Earnings deckThird Quarter 2024
2024-11-01PresentationQ3 024 Fact Sheet (opens in new window)
2024-07-31Earnings deckSecond Quarter 2024
2024-07-28Earnings deckQ2 2024 Fact Sheet (opens in new window)
2024-05-08Earnings deckFirst Quarter 2024
2024-05-06Earnings deckQ1 2024 Fact Sheet (opens in new window)
2024-02-22Earnings deckQ4 2023 Fact Sheet (opens in new window)
2024-01-31PresentationQ4 2023 Teva Pharmaceutical Industries Ltd. Earnings Conference Call Presentation
2023-11-08Earnings deckThird Quarter 2023
2023-11-06Earnings deckQ3 2023 Fact Sheet (opens in new window)
2023-08-02Earnings deckSecond Quarter 2023
2023-07-31PresentationQ2 2023 Fact Sheet (opens in new window)
2023-05-10Earnings deckFirst Quarter 2023

TEVA overview · TEVA earnings · TEVA financials · TEVA KPIs · TEVA documents · TEVA ownership · TEVA peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.